/

Batteries & E-Mobility

/

Eisai

Eisai

Eisai

Verified Nov 2026

Batteries & E-Mobility

·

United States flag

Nutley, New Jersey

·

Since 1995

Eisai Inc. is the North American pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., founded in 1995 and headquartered in Nutley, New Jersey. The company employs over 2,000 people and generates an estimated $5–10 billion in annual revenue. It discovers, develops, and markets therapies focused on neurology and oncology, serving the automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors. In 2026, Eisai extended a neurodegenerative disease research partnership with University College London and committed $64 million to expand its UK manufacturing facility for injectable drug packaging.

Eisai

Verified Nov 2026

AT A GLANCE

Founded

1995

Headquarters

United States flag

Nutley, New Jersey

Employees

1,000-5,000

Ownership

Eisai at a glance

Revenue

$5-10B

Est. band

Employees

1,000-5,000

Founded

1995

Headquarters

Nutley, New Jersey

Import activity

37

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

37

Named foreign suppliers

6

Top origins

Germany · United Kingdom · Belgium

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Eisai.

What this tells a buyer

Eisai received 37 recorded shipments, predominantly sourced from Delpharm Huningue in France (18 shipments), internal manufacturing in the United Kingdom (9 shipments), and Siegfried Pharma in Switzerland (4 shipments), with goods also originating from Germany and Belgium.

The company operates research, development, and manufacturing operations across multiple locations, including facilities in Pennsylvania, Maryland, Hatfield England, and China, and develops targeted therapeutics such as monoclonal antibodies and antibody-drug conjugates.

Eisai is a private subsidiary of a publicly traded Japanese parent company and maintains a significant position in the North American pharmaceutical market with a portfolio addressing Alzheimer's disease, epilepsy, insomnia, and multiple cancer types.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

31 years in operation (founded 1995).

37 US import shipments on record.

Overview

Eisai Inc. is the North American pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., founded in 1995 and headquartered in Nutley, New Jersey. The company employs over 2,000 people and generates an estimated $5–10 billion in annual revenue. It discovers, develops, and markets therapies focused on neurology and oncology, serving the automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors. In 2026, Eisai extended a neurodegenerative disease research partnership with University College London and committed $64 million to expand its UK manufacturing facility for injectable drug packaging.

At a glance

Attribute

Detail

Founded

1995

Headquarters

Nutley, New Jersey

Employees

1,000-5,000

Revenue

$5-10B (estimated)

Primary capability

Batteries & E-Mobility

What Eisai makes

The company operates research, development, and manufacturing operations across multiple locations, including facilities in Pennsylvania, Maryland, Hatfield England, and China, and develops targeted therapeutics such as monoclonal antibodies and antibody-drug conjugates.

Trade and customs footprint

Eisai received 37 recorded shipments, predominantly sourced from Delpharm Huningue in France (18 shipments), internal manufacturing in the United Kingdom (9 shipments), and Siegfried Pharma in Switzerland (4 shipments), with goods also originating from Germany and Belgium. US customs bill-of-lading records list 37 inbound shipments across 6 foreign suppliers, with top origins including Germany · United Kingdom · Belgium.

Latest developments

Facilities

Eisai is headquartered in Nutley, New Jersey. Public sources also reference these locations:

Company details

Eisai is a private subsidiary of a publicly traded Japanese parent company and maintains a significant position in the North American pharmaceutical market with a portfolio addressing Alzheimer's disease, epilepsy, insomnia, and multiple cancer types. Eisai was founded in 1995, has an estimated 1,000-5,000 employees, and is headquartered in Nutley, New Jersey. On the LightSource stability read it is rated "Established & active": 31 years in operation (founded 1995). 37 US import shipments on record.

Frequently asked questions

What does Eisai make?

Eisai Inc. is the North American pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., founded in 1995 and headquartered in Nutley, New Jersey. The company employs over 2,000 people and generates an estimated $5–10 billion in annual revenue. It discovers, develops, and markets therapies focused on neurology and oncology, serving the automotive, electric-vehicle, medical, renewable-energy, and industrial-equipment sectors. In 2026, Eisai extended a neurodegenerative disease research partnership with University College London and committed $64 million to expand its UK manufacturing facility for injectable drug packaging.

Where is Eisai headquartered?

Eisai is headquartered in Nutley, New Jersey (200 Metro Blvd, Nutley, New Jersey, 07110-6102).

When was Eisai founded?

Eisai was founded in 1995.

How big is Eisai?

Eisai has an estimated 1,000-5,000 employees, with revenue in the $5-10B range (estimated).

Does Eisai import from overseas suppliers?

US customs bill-of-lading records show 37 inbound shipments for Eisai, with top origins including Germany · United Kingdom · Belgium.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Nutley, New Jersey (HQ)Headquarters · United States
Nutley, New Jersey (HQ)200 Metro Blvd, Nutley, New Jersey, 07110-6102, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.